Stocks › TGTX
TG Therapeutics TGTX
US equityMarket cap rank #1443
$63.34 −$1.54 (-2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.21 -0.21%
Open$64.10
Prev close$64.88
Day range$63.12 – $65.64
Volume2.09M
Market cap$9.57B
P/E (TTM)94.5
Dividend yield–
TGTX Stock News
Headlines matching TG Therapeutics or the TGTX ticker, most recent first.
- H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78
- TG Therapeutics (TGTX) Receives a Buy From H.C. Wainwright
- B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 Positive
- B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)
- BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $21 Positive
- TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75
- H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $78 Positive
- J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $72 Positive
- BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $20 Positive
- H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $70
- TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $75 Positive
- J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $65
- Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $83
- TG Therapeutics (TGTX) Gets a Buy From H.C. Wainwright
- H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $77 Positive
No comments yet — be the first to weigh in on TGTX.
Sign in to join the discussion.